December 19, 2023 – Henry Schein, Inc. introduced that the Board of Administrators has appointed Carole T. Faig as an unbiased director till the 2024 Annual Assembly of Stockholders in Could, when she is anticipated to face for re-election for the 2024 elections. Director by vote of the Firm's stockholders .

Ms. Faig brings to Henry Schein intensive experience in finance, audit and public accounting and specific expertise within the healthcare trade, together with hospitals, well being insurers, biotechnology and medical machine corporations. Earlier than retiring in July 2021, Ms. Faig served in numerous management roles following her 38-year profession at Ernst & Younger LLP (EY), together with US Well being Chief and West Area Well being and Life Sciences Chief, the place she was liable for creating and driving EY's technique to develop its healthcare follow in a quickly altering setting. Ms. Faig earned a Bachelor of Enterprise Administration diploma in accounting from Sam Houston State College and is an authorized public accountant.

Ms. Faig presently serves on the boards of three corporations, the place she chairs the Audit Committee: Cue Well being, a Nasdaq-listed firm, and Affinia Therapeutics and QuVa Pharma, personal equity-backed personal corporations. An advocate for variety, she served on EY's Gender Fairness Job Drive and obtained EY's Chairman's Worth Award and Americas Assurance Inclusive Management Award in recognition of her dedication to constructing an inclusive office.

Be taught extra